Industry Focus Transcripts

The Keystone XL Pipeline has been cleared to run through Nebraska, but TransCanada still has a lot of work to do.

Bruce Linton talks with us about running the biggest pure-play marijuana company, and the future of the marijuana industry.

After grappling with store closures, warm weather, and weak traffic, department stores may finally have a holiday quarter to get excited about.

Industry Focus: Financials sets the record straight about a few common financial fictions on topics ranging from investing in stocks to using credit cards.

The company may be selling off the bulk of its media business, and the bidding war is likely to be fierce.

In an all-too-often boom-or-bust sector like healthcare, it’s critical to make sure you’re diversifying your bets wisely.

The Industry Focus: Financials podcast looks at the two tax bills currently making their way through Congress, the differences between them, and the likely winners and losers if a bill passes.

Shares skyrocketed on a fantastic earnings report, but there are still some big concerns about this company's long-term future.

Demand for natural gas has been spiking in the last few years, and it’s only projected to grow from here.

A flurry of news has investors clamoring to add Nektar Therapeutics to their portfolios.

B-Dubs might be going private. Here’s what Roark is offering, and what this means for the company, its shareholders and the struggling restaurant industry.

Two Fools discuss the automated substitute for financial advisors that has surged in popularity.

Despite Tencent's new 10% stake in Snap, the Snapchat operator continues to show discouraging results.

Utilities are often overlooked in favor of flashier companies, but all kinds of long-term investors could benefit from some exposure to the sector.

While a combined entity would make for a formidable competitor in the wireless industry, the prospect appears increasingly unlikely despite two attempts in three years.

The much-maligned drugmaker is making progress, but it's not out of the woods yet. Plus, why Keryx Pharmaceuticals shares tumbled despite winning a key FDA approval.

Industry Focus: Financials considers the meaning and impact behind Trump's pick to chair the Federal Reserve, the U.K. central bank's move to raise interest rates, and the blocking of the CFPB's class-action lawsuit rule.

Microsoft and Amazon popped this week on fantastic earnings reports -- here’s what the market was so excited about.

The toy industry’s biggest two companies are telling two very different stories this quarter.

Marijuana use is growing quickly, but that isn’t the only reason Constellation Brands is taking an equity stake in Canopy Growth.